TrialPanorama/TrialPanorama-database huggingface dataset:
Study 20456103 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 20456103 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 16647514 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10418645 — Surrogate Endpoint (SUR): Blood pressure
Study 3104433 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 21181364 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 21181364 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 21181364 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21181364 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21181364 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 21181364 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8606898 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 26547513 — Predictive Biomarker (PRD): PTN mRNA
Genes: PTN; HBNF1; NEGF1
Study 22221140 — Predictive Biomarker (PRD): TACR1 mRNA
Genes: TACR1; NK1R; TAC1R
Study 12243129 — Surrogate Endpoint (SUR): Blood pressure
Study 27100286 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 18458658 — Surrogate Endpoint (SUR): Serum creatinine
Study 2547137 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15793055 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 15793055 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 28535474 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 26256990 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 22855267 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 22855267 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 10893651 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8840357 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 8840357 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 24918373 — Predictive Biomarker (PRD): IL17RA mRNA
Genes: IL17RA; IL17R
Study 24918373 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 28664834 — Surrogate Endpoint (SUR): Forced vital capacity
Study 25600572 — Predictive Biomarker (PRD): Liver iron
Study 18412642 — Surrogate Endpoint (SUR): Blood pressure
Study 16988273 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 16988273 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 16988273 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 11881315 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27762628 — Surrogate Endpoint (SUR): Blood pressure
Study 22160450 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 11960300 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11960300 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 30608001 — Surrogate Endpoint (SUR): Serum triglycerides
Study 26445141 — Predictive Biomarker (PRD): CRHBP mRNA
Genes: CRHBP; CRFBP
Study 26445141 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 26445141 — Predictive Biomarker (PRD): CRHR1 mRNA
Genes: CRHR1; CRFR; CRFR1; CRHR
Study 26445141 — Predictive Biomarker (PRD): HSD11B1 mRNA
Genes: HSD11B1; HSD11; HSD11L; SDR26C1
Study 17544884 — Surrogate Endpoint (SUR): Blood pressure
Study 8027961 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8027961 — Surrogate Endpoint (SUR): Blood pressure
Study 31309699 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31309699 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25494860 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 9054253 — Surrogate Endpoint (SUR): Blood pressure
Study 3662745 — Surrogate Endpoint (SUR): Blood pressure
Study 24009303 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study 3888810 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 29424786 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25259745 — Surrogate Endpoint (SUR): Blood pressure
Study 16631880 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 27476829 — Surrogate Endpoint (SUR): Probing pocket depth
Study 9272412 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 23046014 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 20628391 — Safety Biomarker (SAF): UGT1A1
Genes: UGT1A
Study 20628391 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 10971310 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23249829 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 23249829 — Surrogate Endpoint (SUR): Blood pressure
Study 23249829 — Surrogate Endpoint (SUR): Serum creatinine
Study 18309160 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 10966249 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 6463915 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31210105 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 31210105 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study 31210105 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 31210105 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 31210105 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25316142 — Safety Biomarker (SAF): Hyaluronic acid
Study 11875329 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 11459198 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 11459198 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 24026258 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24026258 — Surrogate Endpoint (SUR): Serum creatinine
Study 26738606 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study 20591543 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 17954806 — Surrogate Endpoint (SUR): Bone mineral density
Study 7874911 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 396084 — Surrogate Endpoint (SUR): Blood pressure
Study 396084 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study 19404957 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19404957 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8176573 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 2855105 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 2855105 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 11601748 — Surrogate Endpoint (SUR): Forced vital capacity
Study 9529028 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 9529028 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9529028 — Safety Biomarker (SAF): Interleukin 1
Study 26577187 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 18499605 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 9807980 — Surrogate Endpoint (SUR): Blood pressure
Study 7701460 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 9822940 — Surrogate Endpoint (SUR): Blood pressure
Study 9822940 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8130042 — Surrogate Endpoint (SUR): Forced vital capacity
Study 23370149 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 28887058 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19167797 — Surrogate Endpoint (SUR): Blood pressure
Study 11348938 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 23551662 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 21481712 — Surrogate Endpoint (SUR): Blood pressure
Study 21481712 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21481712 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21481712 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19461217 — Surrogate Endpoint (SUR): Serum testosterone
Study 8573224 — Surrogate Endpoint (SUR): Blood pressure
Study 19815485 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 19815485 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 19815485 — Surrogate Endpoint (SUR): Serum testosterone
Study 16431255 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 16431255 — Surrogate Endpoint (SUR): Serum calcium
Study 3277485 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31584517 — Surrogate Endpoint (SUR): Blood pressure
Study 26047319 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26047319 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study 26047319 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26047319 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 26047319 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 26047319 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 26047319 — Predictive Biomarker (PRD): MSR1 mRNA
Genes: MSR1; SCARA1
Study 26047319 — Predictive Biomarker (PRD): RNASEL mRNA
Genes: RNASEL; RNS4
Study 26047319 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 26047319 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21173438 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 18332075 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 25185131 — Predictive Biomarker (PRD): NE
Study 25185131 — Surrogate Endpoint (SUR): Blood pressure
Study 18326972 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study 30481760 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 27846366 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 7487368 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7487368 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 2725277 — Surrogate Endpoint (SUR): Blood pressure
Study 29939279 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29939279 — Surrogate Endpoint (SUR): Blood pressure
Study 21326271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8860099 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 94402 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 94402 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 28514081 — Surrogate Endpoint (SUR): Blood pressure
Study 25876706 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25016366 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 22503761 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 8862216 — Surrogate Endpoint (SUR): Blood pressure
Study 28290765 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 25857320 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 21664658 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 11408849 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 25003151 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 25003151 — Surrogate Endpoint (SUR): Blood pressure
Study 22370325 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 7562100 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 24550352 — Safety Biomarker (SAF): Reactive oxygen species
Study 17063830 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17063830 — Safety Biomarker (SAF): IL-6 and IL-10
Study 23902888 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23902888 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 15580061 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15580061 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11349386 — Surrogate Endpoint (SUR): Blood pressure
Study 11349386 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study 7964138 — Predictive Biomarker (PRD): BSG mRNA
Genes: BSG; UNQ6505/PRO21383
Study 3069935 — Surrogate Endpoint (SUR): Blood pressure
Study 21421511 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9855026 — Surrogate Endpoint (SUR): Blood pressure
Study 20164324 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 17075823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12532160 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 8856250 — Surrogate Endpoint (SUR): Serum creatinine
Study 20057309 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10376615 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10376615 — Surrogate Endpoint (SUR): Blood pressure
Study 7046702 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 24690329 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8792507 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8792507 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 1731858 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17561927 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 15759025 — Surrogate Endpoint (SUR): Blood pressure
Study 10223241 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 2195861 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 30949831 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30949831 — Surrogate Endpoint (SUR): Blood pressure
Study 27330719 — Predictive Biomarker (PRD): ADRB3 mRNA
Genes: ADRB3; ADRB3R; B3AR
Study 27330719 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 22025146 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 22025146 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22025146 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 29807962 — Safety Biomarker (SAF): Hyaluronic acid
Study 6800539 — Surrogate Endpoint (SUR): Blood pressure
Study 9132327 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 23075413 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study 12538507 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 22476387 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 22476387 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 17988199 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 12842681 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8840373 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23408502 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20529449 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 16626379 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 30423452 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 19317815 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19317815 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 19317815 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17616788 — Surrogate Endpoint (SUR): Bone mineral density
Study 15056835 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12599448 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7847966 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 2278370 — Surrogate Endpoint (SUR): Blood pressure
Study 20001132 — Surrogate Endpoint (SUR): Blood pressure
Study 14574084 — Surrogate Endpoint (SUR): Blood pressure
Study 27214383 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 27214383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22331951 — Predictive Biomarker (PRD): Hormone receptor
Study 20819882 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 8875972 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21054881 — Surrogate Endpoint (SUR): Blood pressure
Study 16003858 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 498916 — Surrogate Endpoint (SUR): Blood pressure
Study 31484659 — Surrogate Endpoint (SUR): Serum triglycerides
Study 26271371 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 19843034 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 28011798 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 17928597 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 17928597 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 11681650 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 25015597 — Surrogate Endpoint (SUR): Serum sodium
Study 20466437 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 11113686 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 28167482 — Surrogate Endpoint (SUR): Blood pressure
Study 23108892 — Predictive Biomarker (PRD): COL4A3 mRNA
Genes: COL4A3
Study 27417903 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18248643 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 7731143 — Surrogate Endpoint (SUR): Blood pressure
Study 31732300 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 989373 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 30506499 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 25262475 — Surrogate Endpoint (SUR): Blood pressure
Study 18650513 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11111812 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 11111812 — Surrogate Endpoint (SUR): Serum creatinine
Study 11111812 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 9074537 — Predictive Biomarker (PRD): NE
Study 21847569 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 8887291 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 30316200 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study 27138295 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 24506852 — Monitoring Biomarker (MOI): Procalcitonin
Study 17561808 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 17561808 — Surrogate Endpoint (SUR): Blood pressure
Study 6258959 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 9447279 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 9447279 — Surrogate Endpoint (SUR): Bone mineral density
Study 24228534 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27683800 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21346163 — Surrogate Endpoint (SUR): Blood pressure
Study 14987324 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 19656736 — Surrogate Endpoint (SUR): Blood pressure
Study 14968327 — Surrogate Endpoint (SUR): Serum calcium
Study 18608041 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11044791 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11044791 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26503204 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26503204 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 26503204 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 26503204 — Predictive Biomarker (PRD): Hormone receptor
Study 20164561 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 10798650 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 20807884 — Surrogate Endpoint (SUR): Blood pressure
Study 18050196 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study 18050196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 2955205 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 2955205 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30572473 — Predictive Biomarker (PRD): NES mRNA
Genes: NES; Nbla00170
Study 19271172 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 19271172 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 19271172 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 19271172 — Safety Biomarker (SAF): Interleukin 12
Study 19271172 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 19271172 — Monitoring Biomarker (MOI): HBV DNA
Study 10940797 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2